- Loading stock data...
Teladoc Health, Inc is a US telemedicine and virtual healthcare company. Its headquarter is in Purchase, NY. Teladoc Health’s services was available in more than 130 countries in 2019.
Teladoc Health provides services including telemedicine, medical opinions and AI analytics as well as licensed platform services. In particular, Teladoc Health provides on-demand remote healthcare using telephone, video conferencing software and mobile apps.
Teladoc Health acquired companies such as BetterHelp in 2015, Best Doctors in 2017, Advance Medical in 2018, and Livongo in 2020.
This 10-months stock chart of Teladoc Health is output by utilizing a plugin provided by “finviz.com”. Thus, Watanabe & Brothers’ Investment is not in a position to guarantee its accuracy and timeliness. If you have any questions about interpretation of individual stock charts, please contact to “finviz.com“.
Watanabe & Brothers’ Investment is holding shares of Teladoc Health. We provide these information solely for informational purpose and not for the purpose of soliciting investment in, or as a recommendation to purchase or sell any specific products.
Latest News and Analysis on Teladoc Health, Inc.
Teladoc Health (NYSE: TDOC) announced its 2021 Q3 financial results on October 27, 2021. According to the announcement, total revenue was up 108% (9 months, YoY). Among them, subscription-based Access Fees revenue was up 133%. In addition, the other revenues, including that for chronic care, were up 177%. On the other hand, Teladoc recorded upContinue reading “Teladoc showed Strong Growth in its Acquired Business”
As many people know, Teladoc Health’s stock price had fallen by more than 50% since it hit a record high on February 7, 2021. What is behind the recent fall in stock price of Teladoc, which has been rumored to be a promising stock in the future? One reason for the stock price stagnation isContinue reading “What’s Teladoc’s Future after Acquisition of Livongo”
Teladoc Health (NYSE: TDOC) announced its 2021 Q2 financial results on July 27th. According to the announcement, total revenue was up 109% (YoY, 3 months). However, Teladoc recorded operating loss and net loss of 78.9 million USD and 133.8 million USD, respectively. In this regard, these amounts of operating loss and net loss were mainlyContinue reading “Teladoc recorded Positive Cash Flow in 2021 Q2”
Teladoc Health (NYSE: TDOC) announced its 2021 Q1 earning results on April 28th, 2021. According to the announcement, its total revenue showed significant growth of 151% (YoY, 3 months). In this regard, subscription-based access fee revenue was up 183% and visit fee revenue was up 24% (YoY, 3 months). In addition, U.S. paid membership wasContinue reading “Teladoc recorded 151% Growth in Its Total Revenue”
Important Notice: This webpage was originally prepared in English, and translated into the other languages with plugin utilizing Google Translation API. We hereby notify that the translations are provided only for the sake of reference, and any opinions or statements here should be interpreted in original English.